DNA sequencing Market | Abbott Laboratories, Agilent Technologies, Inc, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc, LI-COR Biosciences, Inc, Pacific Biosciences of California, Inc, SIEMENS AG; PerkinElmer Inc, The

A new market research report on the Global DNA sequencing market has introduced by KD Market Insights. The report is dedicated to in-depth industry analysis of the global DNA sequencing market. The Global DNA sequencing analysis is broken down on different segmentation levels including Market By Product, By Application, By Technology, By End User.

DNA sequencing is a molecular technique that helps determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $6,243 million in 2017, and is anticipated to reach $25,470 million by 2025, registering a CAGR of 19.0% from 2017 to 2025. DNA sequencing has revolutionized molecular biology and genomics research. The knowledge of DNA sequences of genes and other parts of the genome of organisms has become essential for life-science research and also in applied fields, such as forensics, cancer diagnostics, and others. Through this method, billions of DNA strands can be sequenced efficiently. DNA sequencing has made it possible to conveniently sequence whole genomes and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. They are utilized through varied interventions, such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.

Get Report Sample Copy @ https://www.kdmarketinsights.com/sample/4326

Technological advancements in sequencing equipment, surge in applications of DNA sequencing, and increase in genome mapping programs drive the global DNA sequencing market. In addition, rise in awareness pertaining to DNA sequencing and increase in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitations related to DNA sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, use of cloud computing as a potential data management service and the untapped emerging countries offer lucrative opportunities for the market players.

The DNA sequencing market is segmented based on product, application, technology, end user, and geography. Based on product, it is categorized into consumable, instrument, and service. The consumables segment accounted for a dominant share in 2017 and is expected to maintain this trend during the forecast period. This is attributed to the fact that they are widely used throughout the sample preparation process and other pre-requisite steps of DNA sequencing.

Based on application, it is categorized into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and other applications. The biomarkers & cancer application was the highest revenue contributor in 2017, while the personalized medicine segment is anticipated to grow at the highest rate. The growth for this segment is due to increase in investment in R&D globally and surge in awareness about DNA sequencing applications in precision medicine. Based on technology, the DNA sequencing technology market is classified into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real-time sequencing, chain termination sequencing, and nanopore sequencing technologies. The sequencing by synthesis technology segment accounted for the highest share in 2017 and is estimated to continue this trend throughout the study period as this technology allows both short and long insert paired end reads for high resolution genome sequencing, structural variation detection, sequence assembly, and others.

Based on region, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in the DNA sequencing market in 2017 and is expected to maintain its dominance throughout the forecast period. This is primarily attributed to the higher buying power, availability, and applications that favor the utilization of DNA sequencing. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize DNA sequencing in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, rise in disposable income, and rapidly development in economic conditions.

Key Benefits for DNA sequencing Market:
- The study provides an in-depth analysis of the global DNA sequencing market and the current trends and future estimations to elucidate the imminent investment pockets.
- The report presents quantitative analysis of the market from 2017 to 2025 to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on product assists to understand the trends in the industry.
- Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry

Key DNA sequencing Market:

By Product
- Consumable
- Instrument
- Service

By Application
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Forensics
- Other Applications

By Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real-Time Sequencing
- Chain Termination Sequencing
- Nanopore Sequencing

By End User
- Academic & Government Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals & Clinics

By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- Rest of LAMEA

List of Key Players Profiled in the Report
- Abbott Laboratories
- Agilent Technologies, Inc.
- Danaher Corporation (Beckman Coulter, Inc.)
- F. Hoffmann-La Roche Ltd
- Illumina, Inc
- LI-COR Biosciences, Inc.
- Pacific Biosciences of California, Inc.
- SIEMENS AG; PerkinElmer Inc.
- Thermo Fisher Scientific, Inc.

Access Complete Research Report with TOC @ https://www.kdmarketinsights.com/product/dna-sequencing-market-amrr

Table of Content

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top winning strategies
3.4. Market share analysis
3.4.1. Overview
3.5. Patents analysis
3.5.1. Patent analysis, by region
3.5.2. Patent analysis, by year
3.6. Porters five forces analysis
3.7. Market dynamics
3.7.1. Drivers
3.7.1.1. Technological advancements in DNA sequencing
3.7.1.2. Surge in applications of DNA sequencing
3.7.1.3. Increase in partnerships and collaborations
3.7.1.4. Increase in genome mapping programs
3.7.2. Restraints
3.7.2.1. Standardization concerns over DNA sequencing-based diagnostics
3.7.2.2. Dearth of skilled professionals
3.7.2.3. Ethical and legal limitations
3.7.3. Opportunities
3.7.3.1. Lucrative opportunities in emerging markets
3.7.3.2. Cloud computing as a potential data management service
3.7.4. Impact analyses

CHAPTER 4: DNA SEQUENCING MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Consumables
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

CHAPTER 5: DNA SEQUENCING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Biomarker & cancer
5.2.1. Market size and forecast, by region
5.2.2. Market share analysis
5.3. Diagnostics
5.3.1. Market size and forecast, by region
5.3.2. Market share analysis, by country
5.4. Reproductive health
5.4.1. Market size and forecast, by region
5.4.2. Market share analysis, by country
5.5. Personalized medicine
5.5.1. Market size and forecast, by region
5.5.2. Market share analysis, by country
5.6. Forensics
5.6.1. Market size and forecast, by region
5.6.2. Market share analysis
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market share analysis

CHAPTER 6: DNA SEQUENCING MARKET, BY TECHNOLOGY
6.1. Overview
6.1.1. Market size and forecast
6.2. Sequencing by synthesis
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Ion semiconductor sequencing
6.3.1. Market size and forecast, by region
6.3.2. Market share analysis, by country
6.4. Sequencing by ligation
6.4.1. Market size and forecast, by region
6.4.2. Market share analysis, by country
6.5. Pyrosequencing
6.5.1. Market size and forecast, by region
6.5.2. Market share analysis, by country
6.6. Single-molecule real-time sequencing
6.6.1. Market size and forecast, by region
6.6.2. Market share analysis, by country
6.7. Chain termination technology
6.7.1. Market size and forecast, by region
6.7.2. Market share analysis, by country
6.8. Nanopore sequencing
6.8.1. Market size and forecast, by region
6.8.2. Market share analysis, by country

CHAPTER 7: DNA SEQUENCING MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Academic & government research institute
7.2.1. Market size and forecast, by region
7.2.2. Market share analysis, by country
7.3. Pharmaceutical companies
7.3.1. Market size and forecast, by region
7.3.2. Market share analysis, by country
7.4. Biotechnology companies
7.4.1. Market size and forecast, by region
7.4.2. Market share analysis
7.5. Hospital & clinics
7.5.1. Market size and forecast, by region
7.5.2. Market share analysis

CHAPTER 8: DNA SEQUENCING MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by country
8.2.2.1. U.S.
8.2.2.1.1. U.S. DNA sequencing market, by product
8.2.2.1.2. U.S. DNA sequencing market, by application
8.2.2.1.3. U.S. DNA sequencing market, by technology
8.2.2.1.4. U.S. DNA sequencing market, by end user
8.2.2.2. Canada
8.2.2.2.1. Canada DNA sequencing market, by product
8.2.2.2.2. Canada DNA sequencing market, by application
8.2.2.2.3. Canada DNA sequencing market, by technology
8.2.2.2.4. Canada DNA sequencing market, by end user
8.2.2.3. Mexico
8.2.2.3.1. Mexico DNA sequencing market, by product
8.2.2.3.2. Mexico DNA sequencing market, by application
8.2.2.3.3. Mexico DNA sequencing market, by technology
8.2.2.3.4. Mexico DNA sequencing market, by end user
8.2.3. Market size and forecast, by product
8.2.4. Market size and forecast, by application
8.2.5. Market size and forecast, by technology
8.2.6. Market size and forecast, by end user
8.3. Europe
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast, by country

Continue @...

Check for Discount @ https://www.kdmarketinsights.com/discount/4326

Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
https://prnewslight.blogspot.com/
https://newstrendmirror.blogspot.com/

About Us:

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

This release was published on openPR.